Introducing the Cancer Research UK Advanced Radiotherapy Technologies Network (ART-NET)

Introducing the Cancer Research UK Advanced Radiotherapy Technologies Network (ART-NET)

We live in a golden age for the development of innovative radiotherapy technologies. Three major new treatment platforms are currently at various stages of being implemented globally: stereotactic ablative radiotherapy (SABR)[1]; MR-guided radiotherapy (MR-Linac)[2]; and proton beam therapy (PBT)[3...

Full description

Bibliographic Details
Main Authors:	Harrington, K, Hall, E, Hawkins, M, Henry, A, MacKay, R, Maughan, T, McDonald, A, Nutting, C, Oelfke, U, Sebag-Montefiore, D, Sharma, R, van Herk, M, Faivre-Finn, C
Format:	Journal article
Language:	English
Published:	Elsevier 2017

Similar Items

Advanced Radiotherapy Technologies Network in the UK (ART-NET) - focus on lung cancer
by: Brown, S, et al.
Published: (2018)

Methodological considerations in the evaluation of radiotherapy technologies.
by: Burnet, N, et al.
Published: (2012)

Methodological Considerations in the Evaluation of Radiotherapy Technologies
by: Burnet, N, et al.
Published: (2012)

Radiotherapy research priorities for the UK.
by: Maughan, T, et al.
Published: (2010)

Pelvic re-irradiation using stereotactic ablative radiotherapy (SABR): A systematic review.
by: Murray, L, et al.
Published: (2017)

Introducing Ontological CP−Nets
by: Noia, T, et al.
Published: (2012)

Introducing Op art /
by: 429040 Lancaster, John
Published: (1973)

Preliminary phase IISOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (IRT) in patients (pts) with locally advanced rectal cancer (LARC).
by: Glynne-Jones, R, et al.
Published: (2004)

Stereotactic body radiotherapy for oligometastases.
by: Tree, A, et al.
Published: (2013)

Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer.
by: Newbold, K, et al.
Published: (2008)

Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).
by: Glynne-Jones, R, et al.
Published: (2005)

Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial.
by: Buettner, F, et al.
Published: (2012)

Challenges in integrating 18FDG PET-CT into radiotherapy planning of head and neck cancer.
by: Dandekar, P, et al.
Published: (2010)

Initial results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015
by: Muirhead, R, et al.
Published: (2016)

Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial.
by: Gulliford, S, et al.
Published: (2012)

Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer.
by: Holyoake, D, et al.
Published: (2016)

A new opportunity for radiotherapy research in the UK.
by: Maughan, T
Published: (2009)

A NetLogo® model for introducing students to genetic algorithms
by: Giner Sanz, Juan Jose, et al.
Published: (2020)

COVID RT - Assessing the impact of COVID-19 on radiotherapy in the UK. A National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group Initiative in Partnership with the Royal College of Radiologists, the Society of Radiographers and the Institute of Physics and Engineering in Medicine
by: Lewis, PJ, et al.
Published: (2020)

Improving radiotherapy quality assurance in clinical trials: assessment of target volume delineation of the pre-accrual benchmark case.
by: Gwynne, S, et al.
Published: (2013)

A novel pretrial contouring exercise for the UK led PersonaLising Anal cancer radioTherapy dOse (PLATO) trial
by: Robinson, M, et al.
Published: (2017)

Fusobacterium nucleatum, rectal cancer and radiotherapy
by: Mann, EH, et al.
Published: (2020)

A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS
by: Gollins, S, et al.
Published: (2019)

Skills instruction in a language arts program /
by: 210700 Foster, Graham, et al.

Stereotactic body radiotherapy for liver metastases.
by: Aitken, K, et al.
Published: (2015)

Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)
by: Strauss, V, et al.
Published: (2019)

Modulation of myocardial creatine transporter levels and the effects of gene regulation and post-translational modification on its function
by: Sebag-Montefiore, L
Published: (2012)

CERN-based experiments and Monte-Carlo studies on focused dose delivery with very high energy electron (VHEE) beams for radiotherapy applications
by: Whitmore, L, et al.
Published: (2024)

A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study.
by: Sebag-Montefiore, D, et al.
Published: (2005)

A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
by: Glynne-Jones, R, et al.
Published: (2007)

Clinical development of new drug-radiotherapy combinations.
by: Sharma, R, et al.
Published: (2016)

A randomised trial of conventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
by: Khoo, V, et al.
Published: (2018)

SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer
by: Virdee, P, et al.
Published: (2017)

Accelerating NetZero: introducing a novel financial approach and new narratives for retrofit
by: Topouzi, M, et al.
Published: (2024)

P-233: SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer
by: Virdee, P, et al.
Published: (2017)

The political economy of North Sea Oil /
by: 268823 MacKay, Donald Iain, et al.
Published: (1975)

SCALOP-2: A multi-centre randomised trial of induction chemotherapy followed by capecitabine +/-nelfinavir with high or standard dose radiotherapy for locally advanced pancreatic cancer (LAPC): Results of stage 1 - the non-randomised dose-finding component
by: Mukherjee, S, et al.
Published: (2018)

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers
by: Harrington, K, et al.
Published: (2011)

The effects of introducing artemether-lumefantrine malaria treatment and insecticide-impregnated bed nets to an elective surgical hospital.
by: Abram, S, et al.
Published: (2011)

Initial UK Experience of Stereotactic Body Radiotherapy for Extracranial Oligometastases: Can We Change the Therapeutic Paradigm?
by: Aitken, K, et al.
Published: (2015)